MetaCap

CDT Equity (CDT) vs Sunshine Biopharma (SBFM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

Sunshine Biopharma is the larger company by market cap ($1.5 million vs $28,759), about 51.3 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CDT-4.31%SBFM-38.57%
+2%-19%-41%
Oct 7, 20261 yearOct 8, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CDT versus SBFM key metrics
MetricCDTSBFM
Share price$0.7094$0.3421
Market cap$28.76K$1.47M
1-day change-11.33%-20.44%
P/E ratio (TTM)0.00—
Forward P/E—0.00
EPS (TTM)$90,812.50$-9.45
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$28,400.00$24.30
52-week low$0.70$0.34
Distance from 52-week high-100.00%-98.59%
Analyst consensus—none
Avg. price target upside—+16269.48%
Average volume188.27K5.25M
Shares outstanding40.54K4.31M
Employees450
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Sunshine Biopharma is about 51.3 times larger than CDT Equity by market value ($1.47M vs $28.76K).

About CDT Equity

CDT stock →

CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.

Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees

About Sunshine Biopharma

SBFM stock →

Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada.

Health Care · Biotechnology: Pharmaceutical Preparations · 50 employees

CDT vs SBFM FAQ

Which is bigger, CDT Equity or Sunshine Biopharma?

Sunshine Biopharma (SBFM) is larger, with a market capitalization of $1.47M compared with $28.76K for CDT Equity (CDT).

Are CDT Equity and Sunshine Biopharma in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons